Navigation Links
Experimental Weight-Loss Drug Seems to Work: Study
Date:4/11/2011

mood changes, while phentermine is more uplifting, he added.

The report is published in the April 11 online edition of The Lancet.

In this multicenter trial, called CONQUER, Gadde's team randomly assigned almost 2,500 overweight and obese men and women to diet and exercise counseling alone or to counseling alongside once-daily low- or high-dose Qnexa in pill form. Low-dose Qnexa contained 7.5 milligrams (mg) of phentermine and 46 mg topiramate, while the high-dose pill contained 15 mg of phentermine and 92 mg of topiramate.

After 56 weeks, patients on either dose of Qnexa had lost significantly more weight than those who only took part in the counseling program, the researchers found.

Those not taking the combo drug had an average weight-loss of 3 pounds, compared with 18 pounds for those on low-dose Qnexa and 22 pounds for those on the high-dose Qnexa.

Moreover, while 21 percent of those in the counseling program alone lost at least 5 percent of their weight, that number rose to 62 percent of those on low-dose Qnexa and 70 percent for those on the high-dose regimen.

In addition, people taking Qnexa saw reductions in their blood pressure, blood cholesterol levels, triglycerides (a blood fat) and blood sugar levels, Gadde's group found.

The ideal candidates for this treatment are obese and overweight people whose weight is affecting their health, Gadde said.

"When you are looking for weight-loss in patients, it shouldn't be for cosmetic reasons," he said. "An ideal candidate for weight-loss is someone that has obesity-related [health] risks."

Gadde noted that the weight-loss seen in the first year of the trial was maintained in the second year of the trial.

Side effects did occur in some patients, and were especially common at the higher dose. In those taking high-dose Qnexa, the most common side effects were dry mouth (21 percent), paresthesia, or a feeling of "pins and needles" (21 percent)
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Experimental drug achieves unprecedented weight loss
2. Science at a glance: Symposia, research and special events at Experimental Biology 2011
3. A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease
4. Extra Tests Not a Deterrent to Experimental Cancer Therapy
5. 2 Experimental Drugs Show Promise for Rare Pancreatic Cancer
6. Experimental approach may improve healing of diabetic wounds and bed sores
7. Study raises safety concerns about experimental cancer approach
8. First liver transplant patients receive experimental drug to prevent hepatitis C infection
9. Experimental Drug Helps Fight Aggressive Breast Cancer: Report
10. Experimental drug more potent, longer lasting than morphine
11. Experimental vaccine sets sights on lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Weight-Loss Drug Seems to Work: Study
(Date:9/23/2014)... (PRWEB) September 23, 2014 The Fish ... rate over the past five years. Growth in per ... has encouraged Canadians to consume more fish and seafood ... food retailers and food-service establishments to increase their purchases ... revenue. Additionally, strong economic growth in much of the ...
(Date:9/23/2014)... The inaugural single day event in Japan ... Tokyo Gardens in Tokyo. Clinical data scientists will meet and ... The second single day event in China will ... The clinical data scientists attending this event will discuss topics ... which display data collected in clinical studies and beyond. ...
(Date:9/23/2014)... Mel Frank, also known as the “Godfather of ... He is perhaps one of the industry’s most important ... a special elective course on growing marijuana on September ... Oaksterdam University in Oakland, California. This day-long seminar ... manicuring, and identifying preflowers and outdoor growing. , The ...
(Date:9/23/2014)... Oaksterdam University has begun publishing a blog ... post, the University addresses the need for quality training ... The cannabis industry is becoming big business. According to ... boost of more than $600 million in revenues and ... the new legal recreational marijuana market in Washington State ...
(Date:9/23/2014)... Mo. Infants, vocalizations throughout the first year ... and cooing to forming syllables and first words. ... amount of vocalizations may differ between hearing and ... that infant vocalizations are primarily motivated by infants, ... with profound hearing loss who received cochlear implants ...
Breaking Medicine News(10 mins):Health News:Fish and Seafood Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Fish and Seafood Wholesaling in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:Infant cooing, babbling linked to hearing ability, MU researcher finds 2
... A path breaking research published today seems to have ... be able to manufacture their own sperms. Lesbian couples// ... ,Researchers have applied for permission to generate synthetic ... this move will be ethical is a question that ...
... the key to not only stopping heart attacks in ... Researchers at Mount Sinai School of Medicine have shown ... novel contrast agent know as N1177 can detect dangerous, ... findings may help physicians diagnosis a heart attack before ...
... Alirajpur in Jhabua district, beat his wife to death. Reason? ... another young man killed his brother with an arrow when ... owned by him. ,Often the reasons for murders ... entering the neighbour's territory or someone's refusal to lend a ...
... - If you are obese, blame it on your gene. A ... called FTO portray mutation in both their copies, then such people ... people who possess normal copies of the gene. ,Researchers ... of what is happening, this research could give us an answer ...
... M.D., director of the Yale Child Study Center and ... discuss the expansion of the Center’s specialty clinical services ... at Greenwich Library, 101 W. Putnam Ave., Greenwich. ... new clinical services, which will also benefit clients from ...
... Northeastern states in the US are stepping up their efforts ... mercury emissions.// ,Throughout the Northeast, mercury contamination ... that occurs naturally. , It is released ... generating plants. ,Smokestack emissions drift across state ...
Cached Medicine News:Health News:CT Imaging With Novel Contrast Agent May Predict Heart Attack in Waiting 2Health News:Efforts Underway to Fight Alcoholism Among Tribals 2Health News:Efforts Underway to Fight Alcoholism Among Tribals 3Health News:Efforts Underway to Fight Alcoholism Among Tribals 4Health News:US States Get Ready to Fight Mercury Pollution 2
(Date:9/23/2014)... , Sept 23, 2014  Vesselon, Inc. today ... Board of Directors, effective September 15, 2014. Dr. Raths, ... as its placement agent to market a private preferred ... and early stroke treatment. "Jurgen,s deep experience ... be a great asset to Vesselon as we develop ...
(Date:9/23/2014)... DALLAS , September 23, 2014 ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible ... Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to ... Market over the forecast period of 2014 to ... Billion by 2019, at CAGR of 9.6% from ...
(Date:9/23/2014)... , Sept. 23, 2014 A case report ... a SynCardia temporary Total Artificial Heart into a patient ... ventricles were reversed, along with other abnormalities. ... modifying the SynCardia Total Artificial Heart to treat a ... report and video in the Journal of Visualized Experiments ...
Breaking Medicine Technology:Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 41st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 31st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 4
... Korea , May 10 CrystalGenomics, Inc., a novel ... Ascending Dose) study for its novel antibiotic candidate, CG400549, has been ... , , ... targeting ENR (Enoyl-acyl carrier protein reductase, which is a critical enzyme ...
... May 10 Par Pharmaceutical Companies, Inc. (NYSE: ... Generics Limited and Glenmark Generics Inc., USA , has ... that resolves patent litigation related to Glenmark,s challenge to Merck,s ... involving a challenge by Glenmark which sought to launch a ...
Cached Medicine Technology:CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate 2Par's Development and Marketing Partner, Glenmark, Enters Into A Settlement Agreement With Merck To Settle Patent Litigation Over Generic ZETIA(R) 2